The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 04, 2017
Filed:
Dec. 04, 2015
Applicant:
Achillion Pharmaceuticals, Inc., New Haven, CT (US);
Inventors:
Avinash Phadke, Branford, CT (US);
Xiangzhu Wang, Madison, CT (US);
Suoming Zhang, Palo Alto, CA (US);
Atul Agarwal, Hamden, CT (US);
Assignee:
ACHILLION PHARMACEUTICALS, INC., New Haven, CT (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/05 (2006.01); A61K 38/00 (2006.01); C07K 5/02 (2006.01); C07K 5/065 (2006.01); C07K 5/078 (2006.01); C07K 5/06 (2006.01); C07K 5/083 (2006.01); A61K 38/12 (2006.01); A61K 45/06 (2006.01); C07K 5/12 (2006.01);
U.S. Cl.
CPC ...
A61K 38/05 (2013.01); A61K 38/12 (2013.01); A61K 45/06 (2013.01); C07K 5/02 (2013.01); C07K 5/06078 (2013.01); C07K 5/06139 (2013.01); C07K 5/06165 (2013.01); C07K 5/06191 (2013.01); C07K 5/0808 (2013.01); C07K 5/12 (2013.01); A61K 38/00 (2013.01);
Abstract
The invention provides pharmaceutical compositions comprising a compound of formula or a pharmaceutically acceptable salt or hydrate thereof. The compounds disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication, and the invention provides methods for treating Hepatitis C infections.